Related Experiment Videos
Summary
Spleen cells from mice infected with mammary tumor virus (MTV) show cytotoxic activity against MTV-induced tumors. Even MTV-free mice exhibit reactivity due to antigen transmission, indicating immune responses regardless of tumor susceptibility.
Area of Science:
- Immunology
- Oncology
- Virology
Background:
- Mammary tumor virus (MTV) infection in mice can lead to tumor development.
- Immune responses to MTV infection are crucial for understanding tumor pathogenesis.
- Horizontal transmission of MTV antigens can occur, influencing immune reactivity.
Purpose of the Study:
- To investigate the cytotoxic activity of spleen cells from MTV-infected and MTV-free mice against MTV-induced mammary tumor cells.
- To compare immune reactivity between MTV-infected and MTV-free mice with varying tumor susceptibility.
- To identify qualitative differences in immune responses related to mammary tumor risk.
Main Methods:
- Microcytotoxicity assay to measure spleen cell cytotoxic activity.
- Use of BALB/cfC3H females neonatally infected with MTV.
- Use of supposedly MTV-free BALB/c females to assess horizontal transmission effects.
Main Results:
- Spleen cells from MTV-infected BALB/cfC3H females demonstrated significant cytotoxic activity against MTV-induced mammary tumor cells.
- Spleen cells from MTV-free BALB/c females also showed specific reactivity, suggesting immune priming via horizontal MTV antigen transmission.
- No quantitative differences in spleen cell reactivity were observed between MTV-susceptible and MTV-resistant mouse strains.
- Qualitative differences in immune response were noted between mice at risk for tumors and those not at risk.
Conclusions:
- Neonatal MTV infection induces spleen cell-mediated cytotoxicity against MTV-induced tumors.
- Horizontal MTV antigen transmission primes an immune response in MTV-free mice.
- Immune reactivity against MTV-induced tumors is present in both susceptible and resistant mouse strains, but qualitative differences exist based on tumor risk.